Flagship Capital Management Inc. Invests $2.16 Million in CVS Health Corporation $CVS

Flagship Capital Management Inc. purchased a new position in shares of CVS Health Corporation (NYSE:CVS) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 27,274 shares of the pharmacy operator’s stock, valued at approximately $2,164,000. CVS Health makes up about 1.5% of Flagship Capital Management Inc.’s investment portfolio, making the stock its 21st biggest holding.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CVS. Harbor Capital Advisors Inc. boosted its position in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its position in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares in the last quarter. Corundum Trust Company INC bought a new position in shares of CVS Health during the third quarter worth $29,000. Front Row Advisors LLC boosted its position in shares of CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after purchasing an additional 371 shares in the last quarter. Finally, GoalVest Advisory LLC bought a new position in shares of CVS Health during the fourth quarter worth $32,000. 80.66% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on CVS shares. Piper Sandler dropped their price objective on shares of CVS Health from $101.00 to $99.00 and set an “overweight” rating on the stock in a report on Tuesday, March 31st. Sanford C. Bernstein upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and raised their price objective for the stock from $91.00 to $94.00 in a report on Thursday, March 12th. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Leerink Partners restated an “outperform” rating and set a $98.00 price objective on shares of CVS Health in a report on Thursday, March 5th. Finally, Argus dropped their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $94.95.

CVS Health Stock Up 0.0%

CVS Health stock opened at $78.82 on Friday. The firm has a market capitalization of $101.02 billion, a PE ratio of 57.12, a P/E/G ratio of 0.82 and a beta of 0.51. The company’s 50-day moving average is $75.82 and its 200-day moving average is $77.76. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. CVS Health’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period in the previous year, the business earned $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s payout ratio is currently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.